Cancer of the larynx in Puerto Rico.
BACKGROUND
Cancer of the larynx is the fourteenth most common cancer in the world. The purpose of this cross-sectional study is to examine the characteristics of laryngeal cancer in Puerto Rico. The study evaluates whether this type of cancer is increasing, to what degree gender differences occur; and describe common types of medical treatment.


METHODS
Information on cases of laryngeal cancer for the period of 1997 to 2002 was collected at the Puerto Rico Central Cancer Registry, Department of Health. The incidence of laryngeal cancer in Puerto Rico during the study period was estimated. Sex differences in case-fatality rate and other variables were analyzed. Medical treatments for laryngeal cancer were also analyzed.


RESULTS
The study revealed that the average incidence of laryngeal cancer in Puerto Rico was 3.8 x 100,000 from 1997-1998 and 3.5 x 100,000 from 2001-2002 (-1.07 APC). Of all the cases (n = 848) of laryngeal cancer reviewed, 88% were male. Females were more likely to be diagnosed before age 50 than males (p = 0.02). In this study, women had twice the probability of being alive at the end of the study period (OR = 1.97; CI: 1.14-3.45). The two most frequent types of single treatments for laryngeal cancer were radiation (39%) and surgery (33%).


CONCLUSIONS
Cases oflaryngeal cancer are decreasing in Puerto Rico. Significant differences by sex were observed, especially the stage of the disease at the time of diagnosis. Future studies on medical treatment modalities that better preserve vocal function concurrently with voice therapy are recommended.
Villanueva-Reyes
Albert
A
University of Puerto Rico, Medical Sciences Campus, School of Health Professions, Department of Graduate Programs, Speech-Language Pathology Programs, PO Box 365067, San Juan, PR 00936-5067. albertvillanueva@cprs.rcm.upr.edu
Strand
Edythe
E
Nazario
Cruz María
CM
Irizarry-Ramírez
Margarita
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011647:Puerto Rico / Q000453:epidemiology; D012737:Sex Factors
Laryngoscope. 2003 Sep;113(9):1595-9
12972940
P R Health Sci J. 1996 Dec;15(4):251-5
9097341
N Engl J Med. 2003 Nov 27;349(22):2091-8
14645636
Int J Epidemiol. 1993 Jun;22(3):377-84
8359951
Laryngoscope. 2004 Nov;114(11):1880-91
15510009
Med Arh. 2005;59(4):250-4
16018395
Am J Otolaryngol. 2006 Jan-Feb;27(1):1-4
16360814
Tumori. 2006 Jan-Feb;92(1):72-5
16683387
Eur J Surg Oncol. 2006 Nov;32(9):984-8
16626921
Sao Paulo Med J. 2004 Sep 2;122(5):188-94
15558139
Arch Bronconeumol. 2005 Jun;41(6):307-12
15989887
P R Health Sci J. 2003 Sep;22(3):259-64
14619452
B-ENT. 2005;1(2):97-100
16044742
Asian Pac J Cancer Prev. 2005 Apr-Jun;6(2):202-7
16101334
N Engl J Med. 1991 Jun 13;324(24):1685-90
2034244
J Chin Med Assoc. 2006 Mar;69(3):120-4
16599017
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1378-86
16095847
Bosn J Basic Med Sci. 2004 Oct;4(4):25-7
15628992
Neoplasma. 2005;52(6):483-8
16284693
J Appl Genet. 2005;46(4):407-13
16278516
Int J Cancer. 2005 Sep 1;116(3):451-7
15810012